AavantiBio - Crunchbase Company Profile & Funding

Q: Who invested in AavantiBio?

AavantiBio has 5 investors including RA Capital Management And Sarepta Therapeutics.

Q: When was the last funding round for AavantiBio?

AavantiBio closed its last funding round on obfuscated from a Series A round.

Q: How much funding has AavantiBio raised to date?

AavantiBio has raised obfuscated.

Overview

AavantiBio

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About AavantiBio

CB Rank

35070

AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.

Acquired by

Solid Biosciences

Founded

obfuscation

Private

Series A

Cambridge, Massachusetts, United States

51-100

www.aavantibio.com/

Biotechnology

Genetics

Health Care

Life Science

Funding Rounds

Series A

OBF

obfuscation

Key People

David Howton: Chief Operating Officer & General Counsel
Past Role: Vertex Pharmaceuticals, Chief Compliance Officer
Paul Herzich: Chief Technology Officer

Details

Legal Name

AavantiBio, Inc.

Operating Status

Closed

Company Type

For Profit

Founders

Barry Byrne, Manuela Corti

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Research & Development

AavantiBio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - AavantiBio	5	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
RA Capital Management	—	Series A - AavantiBio	—
RA Capital Management	—	Series A - AavantiBio	—
RA Capital Management	—	Series A - AavantiBio	—
RA Capital Management	—	Series A - AavantiBio	—
RA Capital Management	—	Series A - AavantiBio	—